论文部分内容阅读
1例62岁男性2型糖尿病患者为控制血糖给予正规胰岛素10 U+15%氯化钾5 ml溶于500 ml葡萄糖氯化钠注射液静脉滴注。输注20 min后患者诉胸闷、气短,伴大汗,两肺可闻及散在喘鸣音。立即停止静脉输液,给予吸氧及硫酸沙丁胺醇雾化吸入。血气分析检查:氧分压73 mm Hg(1 mm Hg=0.133 kPa),二氧化碳分压41 mm Hg。停止输液后约80 min,患者喘憋症状明显好转,可平卧入睡。第2天晨起患者喘憋症状消失。改为重组人胰岛素及精蛋白锌重组人胰岛素皮下注射控制血糖。之后,未再出现上述症状。
A 62-year-old man with type 2 diabetes received intravenous drip of 500 ml of glucose and sodium chloride in order to control blood glucose by administering 5 ml of regular insulin 10 U + 15% potassium chloride. Patients complained of chest tightness, shortness of breath, with sweat, lungs can be heard and scattered wheezing 20 minutes after infusion. Immediately stop the intravenous infusion of oxygen and salbutamol sulfate inhalation. Blood gas analysis: oxygen partial pressure of 73 mm Hg (1 mm Hg = 0.133 kPa), partial pressure of carbon dioxide 41 mm Hg. After stopping the infusion about 80 min, patients with wheezing symptoms improved significantly, can be supine to sleep. On the second morning, the symptoms of wheezing disappeared. Change to recombinant human insulin and protamine zinc recombinant human insulin subcutaneous injection to control blood sugar. After that, the above symptoms did not recur.